Fetal carbamazepine syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:370076Q86.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Fetal carbamazepine syndrome, also known as carbamazepine embryopathy, is a rare condition that occurs when a developing baby is exposed to the medication carbamazepine (brand names include Tegretol and Carbatrol) during pregnancy. Carbamazepine is an anticonvulsant drug commonly used to treat epilepsy, bipolar disorder, and certain types of nerve pain. When taken during pregnancy, especially during the first trimester, it can interfere with normal fetal development and cause a pattern of birth defects. The syndrome can affect multiple parts of the body. Common features include distinctive facial characteristics such as a short nose, a long upper lip, upward-slanting eyes, and widely spaced eyes. Children may also be born with fingernail underdevelopment (small or poorly formed nails), growth delays, and a smaller-than-expected head size (microcephaly). Some children experience developmental delays and mild to moderate intellectual disability. Neural tube defects, particularly spina bifida, are a well-known serious complication. Heart defects and cleft palate may also occur in some cases. There is no cure for fetal carbamazepine syndrome, and treatment focuses on managing individual symptoms. Early intervention programs, physical therapy, speech therapy, and special education services can help children reach their full potential. Surgical correction may be needed for heart defects, cleft palate, or neural tube defects. The severity of the condition varies widely — some children are mildly affected while others face more significant challenges. Prevention through careful medication management before and during pregnancy is the most important strategy.

Key symptoms:

Small head sizeShort nose with a flat bridgeLong upper lipUpward-slanting eyesWidely spaced eyesSmall or underdeveloped fingernailsGrowth delays before and after birthDevelopmental delaysMild to moderate intellectual disabilityNeural tube defects such as spina bifidaHeart defectsCleft palate or cleft lipLow birth weightPoor muscle tone in infancy

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026

CARBAMAZEPINE: New indication approved

FDAcompleted
Mar 2026

CARBAMAZEPINE: New indication approved

FDAcompleted
Apr 2025

CARBAMAZEPINE: FDA approved

FDAcompleted
Jan 2024

CARBAMAZEPINE: New indication approved

FDAcompleted
Nov 2022

CARBAMAZEPINE: New indication approved

FDAcompleted
Apr 2020

CARBAMAZEPINE: New indication approved

FDAcompleted
Feb 2015

CARBAMAZEPINE: New indication approved

FDAcompleted
Nov 2011

CARBAMAZEPINE: New indication approved

FDAcompleted
Nov 2009

CARBAMAZEPINE: New indication approved

FDAcompleted
Jul 2008

CARBAMAZEPINE: New indication approved

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Fetal carbamazepine syndrome.

View clinical trials →

No actively recruiting trials found for Fetal carbamazepine syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Fetal carbamazepine syndrome community →

No specialists are currently listed for Fetal carbamazepine syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Fetal carbamazepine syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Fetal carbamazepine syndromeForum →

No community posts yet. Be the first to share your experience with Fetal carbamazepine syndrome.

Start the conversation →

Latest news about Fetal carbamazepine syndrome

No recent news articles for Fetal carbamazepine syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe are my child's specific features, and what does this mean for their development?,What specialists should my child see, and how often?,Are there any heart defects or neural tube defects that need immediate treatment?,What early intervention therapies do you recommend, and when should they start?,What should I watch for as warning signs that something needs urgent attention?,If I plan to have more children, what steps can I take to reduce the risk of this happening again?,Are there any support groups or resources for families affected by this condition?

Common questions about Fetal carbamazepine syndrome

What is Fetal carbamazepine syndrome?

Fetal carbamazepine syndrome, also known as carbamazepine embryopathy, is a rare condition that occurs when a developing baby is exposed to the medication carbamazepine (brand names include Tegretol and Carbatrol) during pregnancy. Carbamazepine is an anticonvulsant drug commonly used to treat epilepsy, bipolar disorder, and certain types of nerve pain. When taken during pregnancy, especially during the first trimester, it can interfere with normal fetal development and cause a pattern of birth defects. The syndrome can affect multiple parts of the body. Common features include distinctive fa

How is Fetal carbamazepine syndrome inherited?

Fetal carbamazepine syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Fetal carbamazepine syndrome typically begin?

Typical onset of Fetal carbamazepine syndrome is neonatal. Age of onset can vary across affected individuals.